Aug 16, 2021 | Securities Class Action Archive
Investors Who Purchased, Or Otherwise Acquired, The Securities Of Live Ventures Between December 28, 2016 And August 3, 2021, Both Dates Inclusive, And Suffered Losses Greater Than $25,000 Encouraged To Contact Kehoe Law Firm, P.C.
On August 13, 2021, a class action lawsuit was filed against Live Ventures Incorporated (“Live Ventures,” “Live,” or the “Company) in United States District Court, District of Nevada, on behalf of investors who purchased, or otherwise acquired, the securities of Live Ventures between December 28, 2016 and August 3, 2021, both dates inclusive (the “Class Period”) and suffered losses.
Throughout the Class Period, according to the class action complaint, the Live Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects.
According to the complaint, the Live Defendants failed to disclose to investors that (1) Live’s earnings per share for FY 2016 was actually only $6.33 per share; (2) the Company used an artificially low share count to boost the earnings per share by 40%; (3) Live had overstated pre-tax income for fiscal 2016 by 20% by including $915,500 of “other income” related to certain amendments that were not negotiated until after the close of the fiscal year; (4) Live’s acquisition of ApplianceSmart did not close during first quarter 2017; (5) using December 30, 2017 as the “acquisition date” and recognizing income therefrom did not conform to generally accepted accounting principles; (6) by falsely stating that the acquisition closed during the quarter, Live recognized bargain purchase gain, which enabled the Company to report positive net income in what would otherwise have been an unprofitable quarter; (7) between fiscal 2016 and fiscal 2018, Live’s CEO received approximately 94% more in compensation than was disclosed to investors; and (8) as a result of the foregoing, the Live Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
INVESTORS WHO PURCHASED LIVE SECURITIES DURING THE CLASS PERIOD AND SUFFERED FINANCIAL LOSSES GREATER THAN $25,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Aug 11, 2021 | Securities Class Action Archive
Investigation To Determine Whether Unregistered Securities Were Sold To Investors Of DFINITY’S ICP Tokens – Investors Who Purchased DFINITY’S ICP Tokens From May 10, 2021 Through The Present And Suffered Losses Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is making investors aware that on August 9, 2021, a class action complaint was filed against DFINITY USA Research LLC, DFINITY Foundation, and Dominic Williams (collectively, “Dfinity” or “Defendants”) in United States District Court, Northern District of California.
According to the class action complaint:
Within the Class Period, from May 10, 2021[] through the present, Defendants have promoted, offered, and sold throughout the United States unregistered securities called ‘ICP tokens,’ and have engaged in insider trading of such securities, in violation of federal law.[] Defendants did not register ICP as a security with the Securities Exchange Commission (‘SEC’); did not qualify for an exemption from the registration requirements; materially defrauded investors in connection with the promotion, offering, and sale of ICP; and have transacted in ICP in the Class Period while in possession of material, non-public information.
On behalf of investors who have purchased ICP in the United States, and who have done so contemporaneously with Defendants’ insider trading, Plaintiff brings suit to recover from Defendants the consideration paid for the ICP tokens, together with interest thereon; and to recover from Defendants their profits resulting from Defendants’ fraudulent conduct and insider trading. Dfinity was required to file registration statements with the SEC for its sale of ICP, but failed to do so. By selling and promoting these unregistered security tokens to investors, and by transacting in them while in possession of material, non-public information, Defendants have reaped billions of dollars in profits. [Emphasis added.]
Additionally, the complaint alleges that “Defendants kept for themselves and sold into the market billions of dollars’ worth of ICP tokens. After insiders began to sell massive quantities of these ICP tokens, and while Plaintiff and the other Class members were transacting in ICP tokens, the price of ICP tokens fell from a high of over $730 after issuance to around $60 today. Even by the volatile standards of the cryptocurrency market, this constituted an astonishing collapse in value.” [Emphasis added.]
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, DFINITY’S ICP TOKENS FROM MAY 10, 2021 THROUGH THE PRESENT AND SUFFERED FINANCIAL LOSSES ARE ENCOURAGED TO CONTACT KEHOE LAW FIRM, P.C., MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected], TO DISCUSS THE CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Aug 4, 2021 | Securities Class Action Archive
Have You Lost Money Investing In Zymergen? Kehoe Law Firm, P.C. Securities Investigation On Behalf Of ZY Investors
Kehoe Law Firm, P.C. is investigating whether Zymergen Inc. (“Zymergen” or the “Company”) (NASDAQ: ZY) violated federal securities laws.
Zymergen investors who have suffered financial losses greater than $50,000 are encouraged to contact Kehoe Law Firm, P.C. to learn more about the securities investigation or potential legal claims.
On August 3, 2021, CNBC.com reported that Zymergen “. . . has yet to start generating product sales and said it now expects revenue from its products to be ‘immaterial’ through 2022.” Stock of the Company, which went public in April 2021, dropped almost 70% on Tuesday, thereby injuring investors.
ZYMERGEN SHAREHOLDERS WITH FINANCIAL LOSSES GREATER THAN $50,000 WHO WISH TO DISCUSS KEHOE LAW FIRM’S CLASS ACTION INVESTIGATION OR HAVE QUESTIONS ABOUT THEIR POTENTIAL LEGAL RIGHTS ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., (215) 792-6676, EXT. 804, [email protected], [email protected].
Jul 29, 2021 | Securities Class Action Archive
Class Action Securities Investigation On Behalf Of CorMedix Inc. Investors Who Acquired The Securities Of CorMedix Inc. Between July 8, 2020 And May 13, 2021, Both Dates Inclusive (the “Class Period”) – Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is making investors of CorMedix Inc. (“CorMedix” or the “Company”) (NASDAQ: CRMD) aware that a class action lawsuit was filed on behalf of a class consisting of all persons and entities, other than the CorMedix Defendants, who purchased, or otherwise acquired, the Company’s securities during the Class Period and suffered losses.
According to the class action complaint, throughout the Class Period, the CorMedix Defendants made materially false and misleading statements regarding the Company’s business, operations, and compliance policies.
Specifically, the CorMedix Defendants, allegedly, made false and/or misleading statements and/or failed to disclose that (i) deficiencies existed with respect to DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; (ii) in light of the foregoing deficiencies, the FDA was unlikely to approve the DefenCath New Drug Application (“NDA”) for catheter-related bloodstream infections (“CRBSIs”) in its present form; (iii) the CorMedix Defendants had downplayed the true scope of the deficiencies with DefenCath’s manufacturing process and/or at the facility responsible for manufacturing DefenCath; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE CORMEDIX SECURITIES BETWEEN JULY 8, 2020 AND MAY 13, 2021, BOTH DATES INCLUSIVE, AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., [email protected], (215) 792-6676, Ext. 804, [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Jul 29, 2021 | Securities Class Action Archive
DiDi Global Inc. Investors With Losses Greater Than $100,000 Encouraged To Contact Kehoe Law Firm, P.C. – Class Action Filed On Behalf of DiDi Global Investors
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI) to determine whether DiDi engaged in securities fraud or other unlawful business practices.
A class action lawsuit has been filed in United States District Court, Central District of California, on behalf of DiDi investors who purchased, or otherwise acquired, the securities of DiDi pursuant and/or traceable to the registration statement and related prospectus (collectively, the “Registration Statement”) issued in connection with DiDi’s June 30, 2021 initial public offering (“IPO” or “Offering”); and/or (2) between June 30, 2021 and July 21, 2021, inclusive (the “Class Period”).
According to the class action complaint, the DiDi Defendants made materially false and/or misleading statements, because they misrepresented and failed to disclose adverse facts pertaining to the Company’s business, operations and prospects, which were known to Defendants, or recklessly disregarded by them.
Specifically, according to the complaint, the Registration Statement was false and/or misleading and/or failed to disclose that (1) the Cyberspace Administration of China (“CAC”) urged Defendant DiDi to delay its IPO; (2) Defendant DiDi “had the problem of collecting personal information in violation of relevant PRC laws and regulations”; (3) Defendant DiDi could not guarantee data security; (4) due to the foregoing, Defendant DiDi would face “serious, perhaps unprecedented, penalties” from relevant authorities; (5) DiDi and its many apps would face an imminent cybersecurity review by the CAC, which could lead to removal of DiDi’s apps from app stores; and (6) as a result, the DiDi Defendants’ statements about the Company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, DIDI SECURITIES IN CONNECTION WITH THE COMPANY’S IPO AND/OR DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., [email protected], [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
Jul 26, 2021 | Securities Class Action Archive
Class Action Securities Investigation On Behalf Of Piedmont Lithium Inc. Investors Who Acquired The Securities Of Piedmont Lithium Between March 16, 2018 and July 19, 2021, Both Dates Inclusive (the “Class Period”) – Piedmont Lithium Investors With Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is making investors of Piedmont Lithium Inc. (“Piedmont Lithium” or the “Company”) (NASDAQ: PLL) aware that a class action lawsuit was filed on behalf of a class consisting of all persons and entities, other than the Piedmont Lithium Defendants, who purchased, or otherwise acquired, the securities of Piedmont Lithium during the Class Period.
The class action lawsuit seeks to recover compensable damages caused by the Piedmont Lithium Defendants’ alleged violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder.
According to the class action complaint filed in United States District Court, Eastern District of New York, the Piedmont Lithium Defendants made materially false and/or misleading statements, because they misrepresented and failed to disclose the following adverse facts pertaining to the Company’s business, operational and financial results, which were known to the Piedmont Lithium Defendants or recklessly disregarded by them.
Specifically, according to the class action lawsuit, the Piedmont Lithium Defendants made false and/or misleading statements and/or failed to disclose that (1) Piedmont Lithium has not, and would not, follow its stated steps or timeline to secure all proper and necessary permits; (2) Piedmont Lithium failed to inform relevant people and governmental authorities of its actual plans; (3) Piedmont Lithium failed to file proper applications with relevant governmental authorities (including state and local authorities); (4) Piedmont Lithium and its lithium business does not have “strong local government support”; and (5) as a result, the Piedmont Lithium Defendants’ public statements were materially false and/or misleading at all relevant times.
INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, THE COMPANY’S SECURITIES BETWEEN MARCH 16, 2018 AND JULY 19, 2021, BOTH DATES INCLUSIVE, AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT MICHAEL YARNOFF, ESQ., [email protected], (215) 792-6676, Ext. 804, [email protected], TO DISCUSS THE SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS.
